As of January 2025, GenMont Biotech Incorporation has a market cap of $52.56M. This makes GenMont Biotech Incorporation the world's 23055th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $61.94M | -5.06% |
2023 | $65.24M | 4.22% |
2022 | $62.60M | -2.67% |
2021 | $64.32M | 9.19% |
2020 | $58.90M | -10.44% |
2019 | $65.77M | -6.74% |
2018 | $70.53M | 16.09% |
2017 | $60.75M | -2.13% |
2016 | $62.07M | -3.09% |
2015 | $64.05M | -32.36% |
2014 | $94.70M | -14.46% |
2013 | $110.70M | -8.95% |
2012 | $121.59M | 30.56% |
2011 | $93.13M | -58.77% |
2010 | $225.86M | 24.29% |
2009 | $181.72M | 537.66% |
2008 | $28.50M | - |